Hypertension Clinical Trial
Official title:
Femoral Artery Block for Reduction of Tourniquet Induced Hypertension: a Randomised Controlled Trial
A randomised controlled trial to assess the impact of femoral artery block on the incidence of tourniquet hypertension in patients receiving cruciate ligament surgery with > 30 minutes of tourniquet under combined anaesthesia (balanced general anaesthesia and femoral nerve blocks).
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | May 31, 2024 |
Est. primary completion date | February 29, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - American Society of Anesthesiologists (ASA) physical status I to III - Receiving cruciate ligament surgery with > 30 minutes of tourniquet - Combined anesthesia (balanced general anesthesia and femoral nerve block) Exclusion Criteria: - Nerve block contraindications (block site infection, allergic to local anesthetic) - Tourniquet contraindications (peripheral vascular disease or neuropathy, previous arterial bypass graft) - Tourniquet inflation time < 30 min - Patient refusal - Pregnant patients - Patients with a active psychiatric disease. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hospital da Luz, Portugal |
Guo YX, Wang GY, Cheng WJ, Yan CZ, Zhao S, Li Z, Liu P, Wang XL. Activation of Opioid Receptors Attenuates Ischemia/Reperfusion Injury in Skeletal Muscle Induced by Tourniquet Placement. Mediators Inflamm. 2021 Jan 15;2021:6699499. doi: 10.1155/2021/6699499. eCollection 2021. — View Citation
Wahal C, Grant SA, Gadsden J, Rambhia MT, Bullock WM. Femoral artery block (FAB) attenuates thigh tourniquet-induced hypertension: a prospective randomized, double-blind, placebo-controlled trial. Reg Anesth Pain Med. 2021 Mar;46(3):228-232. doi: 10.1136/rapm-2020-102113. Epub 2021 Jan 11. — View Citation
Xu F, Wang X, Li Y, Gao F, Yin C, Yu J, Li W, Zhu L, Wang Q. Combined femoral artery block and femoral nerve block reduces thigh tourniquet-induced hypertension. J Clin Anesth. 2023 May;85:111039. doi: 10.1016/j.jclinane.2022.111039. Epub 2022 Dec 20. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Incidence of Tourniquet Hypertension (TH) | Defined as Systolic Blood Pressure (SBP) increased >30% after 30 minutes of tourniquet | Thought intra-operative time (after induction of anesthesia and until emergence from anesthesia) | |
Primary | Systolic blood pressure 30 minutes after tourniquet inflation | SBP at 30 minutes after tourniquet inflation | 30 minutes after tourniquet inflation | |
Primary | Systolic blood pressure 45 minutes after tourniquet inflation | SBP at 45 minutes after tourniquet inflation | 45 minutes after tourniquet inflation | |
Primary | Systolic blood pressure 60 minutes after tourniquet inflation | SBP at 60 minutes after tourniquet inflation | 60 minutes after tourniquet inflation | |
Primary | Systolic blood pressure 75 minutes after tourniquet inflation | SBP at 75 minutes after tourniquet inflation | 75 minutes after tourniquet inflation | |
Primary | Systolic blood pressure 90 minutes after tourniquet inflation | SBP at 90 minutes after tourniquet inflation | 90 minutes after tourniquet inflation | |
Primary | Systolic blood pressure 115 minutes after tourniquet inflation | SBP at 115 minutes after tourniquet inflation | 115 minutes after tourniquet inflation | |
Primary | Systolic blood pressure 130 minutes after tourniquet inflation | SBP at 130 minutes after tourniquet inflation | 130 minutes after tourniquet inflation | |
Primary | Mean arterial pressure (MAP) 30 minutes after tourniquet inflation | MAP at 30 minutes after tourniquet inflation | 30 minutes after tourniquet inflation | |
Primary | Mean arterial pressure 45 minutes after tourniquet inflation | MAP at 45 minutes after tourniquet inflation | 45 minutes after tourniquet inflation | |
Primary | Mean arterial pressure 60 minutes after tourniquet inflation | MAP at 60 minutes after tourniquet inflation | 60 minutes after tourniquet inflation | |
Primary | Mean arterial pressure 75 minutes after tourniquet inflation | MAP at 75 minutes after tourniquet inflation | 75 minutes after tourniquet inflation | |
Primary | Mean arterial pressure 90 minutes after tourniquet inflation | MAP at 90 minutes after tourniquet inflation | 90 minutes after tourniquet inflation | |
Primary | Mean arterial pressure 115 minutes after tourniquet inflation | MAP at 115 minutes after tourniquet inflation | 115 minutes after tourniquet inflation | |
Primary | Mean arterial pressure 130 minutes after tourniquet inflation | MAP at 130 minutes after tourniquet inflation | 130 minutes after tourniquet inflation | |
Primary | Systolic blood pressure variation from baseline at 30 minutes after tourniquet inflation | Variation of SBP compared to baseline at 30 minutes after tourniquet inflation | 30 minutes after tourniquet inflation | |
Primary | Systolic blood pressure variation from baseline at 45 minutes after tourniquet inflation | Variation of SBP compared to baseline at 45 minutes after tourniquet inflation | 45 minutes after tourniquet inflation | |
Primary | Systolic blood pressure variation from baseline at 60 minutes after tourniquet inflation | Variation of SBP compared to baseline at 60 minutes after tourniquet inflation | 60 minutes after tourniquet inflation | |
Primary | Systolic blood pressure variation from baseline at 75 minutes after tourniquet inflation | Variation of SBP compared to baseline at 75 minutes after tourniquet inflation | 75 minutes after tourniquet inflation | |
Primary | Systolic blood pressure variation from baseline at 90 minutes after tourniquet inflation | Variation of SBP compared to baseline at 90 minutes after tourniquet inflation | 90 minutes after tourniquet inflation | |
Primary | Systolic blood pressure variation from baseline at 115 minutes after tourniquet inflation | Variation of SBP compared to baseline at 115 minutes after tourniquet inflation | 115 minutes after tourniquet inflation | |
Primary | Systolic blood pressure variation from baseline at 130 minutes after tourniquet inflation | Variation of SBP compared to baseline at 130 minutes after tourniquet inflation | 130 minutes after tourniquet inflation | |
Primary | Mean arterial pressure variation from baseline at 30 minutes after tourniquet inflation | Variation of MAP compared to baseline at 30 minutes after tourniquet inflation | 30 minutes after tourniquet inflation | |
Primary | Mean arterial pressure variation from baseline at 45 minutes after tourniquet inflation | Variation of MAP compared to baseline at 45 minutes after tourniquet inflation | 45 minutes after tourniquet inflation | |
Primary | Mean arterial pressure variation from baseline at 60 minutes after tourniquet inflation | Variation of MAP compared to baseline at 60 minutes after tourniquet inflation | 60 minutes after tourniquet inflation | |
Primary | Mean arterial pressure variation from baseline at 75 minutes after tourniquet inflation | Variation of MAP compared to baseline at 75 minutes after tourniquet inflation | 75 minutes after tourniquet inflation | |
Primary | Mean arterial pressure variation from baseline at 90 minutes after tourniquet inflation | Variation of MAP compared to baseline at 90 minutes after tourniquet inflation | 90 minutes after tourniquet inflation | |
Primary | Mean arterial pressure variation from baseline at 115 minutes after tourniquet inflation | Variation of MAP compared to baseline at 115 minutes after tourniquet inflation | 115 minutes after tourniquet inflation | |
Primary | Mean arterial pressure variation from baseline at 130 minutes after tourniquet inflation | Variation of MAP compared to baseline at 130 minutes after tourniquet inflation | 130 minutes after tourniquet inflation | |
Secondary | Isosorbide dinitrate administered for TH | mg of isosorbide dinitrate administered for TH | Thought intra-operative time (after induction of anesthesia and until emergence from anesthesia) ) | |
Secondary | Numerical verbal pain scores | Numerical verbal pain scores (from 0 to 10, 10 meaning higher pain) assessed 1 hour after emergence of anesthesia in the post-operative care unit (PACU) | Up to 2 hours after emergence from anesthesia | |
Secondary | Patient post-operative satisfaction | Patient post-operative satisfaction with pain treatment measured 1 hour after emergence of anesthesia in the post-operative care unit using a 5-point Likert-scale, namely: 1 - very unsatisfied, 2 - unsatisfied, 3 - neutral, 4 - satisfied, 5 - very satisfied (with higher scores meaning a higher outcome) | Up to 2 hours after emergence from anesthesia |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |